Drug Type Small molecule drug |
Synonyms 1,1,1,2,2,3,3,4,4,5,5,6,6,6-tetradecafluorohexane, Dimyristoyl Lecithin/Perflexane, Imagent + [11] |
Target- |
Mechanism Cell membrane permeability enhancers |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseWithdrawn |
First Approval Date US (31 May 2002), |
Regulation- |
Molecular FormulaC6F14 |
InChIKeyZJIJAJXFLBMLCK-UHFFFAOYSA-N |
CAS Registry355-42-0 |
Start Date23 Sep 2019 |
Sponsor / Collaborator |
Start Date18 Nov 2014 |
Sponsor / Collaborator |
Start Date12 Dec 2012 |
Sponsor / Collaborator |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
Not Applicable | 11 | 3D ultrasound+perflutren lipid microspheres | qjffgqstxl(qzscfadvme) = itovpevheq uxljuocwuy (utuebkntxs, wdovkrrduh - vcmknqdwek) View more | - | 11 Jul 2023 | ||
Not Applicable | 8 | gnskhxtfid(inlzbdykdm) = nrlhzxwajs ggcmetcdek (xfnqctfzcy, sdcpewdtcv - kxbfyxagbf) View more | - | 11 Jul 2017 |